0000000000527785
AUTHOR
Pierre-henry Gabrielle
showing 13 related works from this author
T054 - Development and validation of a risk-prediction nomogram for good functional response one year after treatment with anti-VEGF in naive-diabeti…
2018
National audience
Incidence, Risk Factors and Outcomes of Submacular Hemorrhage with Loss of Vision in Neovascular Age-Related Macular Degeneration in Daily Clinical P…
2022
Oestrus ovis external ophtalmomyiasis : a case report in Burgundy France
2018
Background External ophtalmomyiasis (EOM) is a zoonosis related to the presence of Oestrus ovis larvae at the ocular level in small ruminants (i.e. ovine, caprine). In humans, EOM is a rare cosmopolitan disorder, mostly described in warm and dry rural areas in patients living close to livestock areas. In metropolitan France (excluding Corsica), EOM is an exceptional disease with less than 25 cases recorded since 1917. Case presentation We report a case of EOM in a 19-years old man in the last week of September 2016 in Burgundy. Conclusion The diagnosis of an EOM in Burgundy, a French region described as cold and humid, is surprising and could be due to a more marked climatic warming during …
Subretinal drusenoid deposits in the elderly in a population-based study (the Montrachet study: Maculopathy, Optic Nerve, nuTRition, neurovAsCular an…
2019
International audience
Perioperative risk of bleeding with antithrombotic agents in macular surgery: a national, prospective, multicentre study
2020
International audience; Purpose To compare the risk of haemorrhagic complications in elective macular surgery between patients with no antithrombotic (AT) treatment (defined as patients with no history of AT therapy or who discontinued AT therapy) and patients who continued AT treatment during the surgery. Methods E-case report forms were prospectively recorded in a database before vitreoretinal surgery and 1 month after. Data on patient characteristics, surgical techniques, haemorrhagic complications and antithrombotic status were collected. Patients with retinal detachment, proliferative diabetic retinopathy and previous retinal haemorrhage were excluded. Results A total of 748 procedures…
Additional file 1: of Oestrus ovis external ophtalmomyiasis: a case report in Burgundy France
2018
Figure S1. Parasite cycle of Oestrus ovis. Oestrus ovis exerts a strict parasitism of the nasal cavities of small sheep and goat ruminants. The viviparous females of Oestrus ovis deposit first-stage larvae (L1) directly in the nasal orifices of sheep and goats. L1 actively penetrate through the nasal orifices and colonize the cornets and septum where they will develop. Once located at the ethmoid level, L1 molt to stage 2 larvae (L2). L2 further ascend from the nasal cavity to the frontal sinuses where they molt to stage 3 larvae (L3). Thereafter, L3 are expelled from the nasal cavity of the host by sneezing via the nasal mucus that subsequently contaminate the soils. Then, L3 turn into a p…
T080 - The incidence of rhegmatogenous retinal detachment in France from 2010 to 2016: seasonal and geographical variations
2018
Development and validation of a risk-prediction nomogram for poor functional response one year after treatment with anti-VEGF in naive-diabetic macul…
2018
International audience
Oedème maculaire diabétique et membrane épirétinienne : quand opérer ?
2018
L’oedème maculaire diabétique (OMD) est une des causes majeures de baisse d’acuité visuelle (BAV) chez les patients diabétiques et sa prise en charge est une problématique de notre pratique quotidienne. Dans le cas d’un OMD associé à une membrane épirétinienne, la chirurgie vitréo-rétinienne peut être envisagée mais il faut faire la distinction entre les différents scénarios.
T024 - The EYE-MI pilot study: a prospective acute coronary syndrome cohort evaluated with retinal optical coherence tomography angiography
2018
Tout savoir sur le treat and extend : organisation et optimisation. Les Cahiers d'Ophtalmologie
2019
La dégénérescence maculaire liée à l’âge (DMLA) est actuellement la première cause de handicap visuel dans les pays développés chez les plus de 50 ans. Elle touche en effet environ 8% de la population française et plus de 25% des plus de 75 ans. La constatation d’une insuffisance de traitement lors d’un régime « réactif » a poussé les cliniciens à proposer d’autres types de régimes. Le « Treat and Extend » (T&E) est né de la volonté d’adapter les intervalles de retraitement des patients pour une prise en charge plus personnalisée.